... Like thousands of savers, Sir Bill Castell rushed to the bank last autumn in a panic. The chairman of the Wellcome Trust, the world's second-largest medical charity after the Bill & Melinda Gates Foundation, switched a large sum of money from Royal Ban...

... On the day Alli was launched in the UK, £1million worth of pills were sold. But it has already provoked controversy. Manufacturer GlaxoSmithKline (GSK) claims it can boost weight loss by up to 50 per cent, helping dieters lose an extra 1lb for every 2lb shed. The...

...engineering antibodies to disarm those T cells. Two competing teams — MacroGenics Inc. and Eli Lilly, and Tolerx Inc. and GlaxoSmithKline— have advanced tests underway. Also, an experimental drug made from a kind of bone marrow stem cell might tamp down overly...

...to help smoking cessation, Chantix (varenicline) manufactured by Pfizer Inc or Zyban(bupropionhydrochloride) manufactured by GlaxoSmithKline, has been associated with reports of behavior changes including hostility, agitation, depressed mood, and suicidal...

...recognised throughout the world. Intas Biopharma is establishing its presence and there is news of Shantha Biotech being on GlaxoSmithKline's radar. Wockhardt, minus its financial mess, is one of the best players in the industry. Watch out for a sizeable deal...

...angiodema, serious skin reaction and accidental injury." On Wednesday the U.S. Food and Drug Administration mandated Pfizer and GlaxoSmithKline to include strong black box warnings on their anti-smoking medication to emphasize the risk drinkers may face, particularly...

...plc (GSK) today announced that it has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2m (£14.2m). The business comprises a portfolio of 13 branded pharmaceuticals...

... Today Ian Haydock Please Login to read the full article. GlaxoSmithKline has decided to discontinue development of remogliflozin etabonate (KGT-1681), a sodium glucose co-transporter-2 (SGLT-2) inhibitor licensed from Japan's ...

...by Switzerland's Roche AG and Gilead Sciences <GILD.O>, while Relenza, an inhaled drug known generically as zanamivir, is made by GlaxoSmithKline <GSK.L> under licence from Australia's Biota Inc <BTA.AX>. The department said that tests showed that the strain...

...AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler AG, Deutsche Bank, DLA Piper, Ericsson, FedEx, Ford, GlaxoSmithKline, Lloyds TSB, NASA, Nestlé, the New York Stock Exchange, Reuters, Shell, Tesco, T-Mobile, the U.S. Department of Energy,...